Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.36 - $11.74 $414,400 - $469,600
40,000 Added 80.0%
90,000 $951,000
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $493,499 - $590,000
50,000 New
50,000 $527,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.2B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Ionic Capital Management LLC Portfolio

Follow Ionic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ionic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ionic Capital Management LLC with notifications on news.